Corporate StrategyNVIDIA BioNeMo Platform Secures Partnerships With Lilly, Thermo Fisher in Drug Discovery AI PushSalvado•Apr 14, 2026
Corporate StrategyNVIDIA Partners with Eli Lilly, Thermo Fisher to Build AI Drug Discovery InfrastructureSalvado•Apr 13, 2026
Corporate FinanceNVIDIA's BioNeMo Platform Secures Eli Lilly Partnership as Biotech AI Competition IntensifiesSalvado•Apr 12, 2026
Corporate StrategyNVIDIA Locks In Pharma Giants Lilly and Thermo Fisher as Biotech AI Race AcceleratesSalvado•Apr 11, 2026
Corporate StrategyNVIDIA Secures Eli Lilly, Thermo Fisher for BioNeMo Platform in Pharma AI PushSalvado•Apr 11, 2026
Corporate StrategyNVIDIA Partners with Eli Lilly, Thermo Fisher to Drive BioNeMo AI Drug Discovery PlatformSalvado•Apr 10, 2026
Corporate FinanceNVIDIA BioNeMo Platform Powers AI Drug Discovery Push by Eli Lilly, Thermo FisherSalvado•Apr 10, 2026
Corporate FinanceAI Chip Stocks Outpace Software Providers as Market Pivots to InfrastructureSalvado•Apr 9, 2026
Biotech InvestmentNVIDIA BioNeMo Platform Secures Lilly and Thermo Fisher as AI Drug Discovery Partnerships AccelerateSalvado•Apr 9, 2026
Corporate Technology InvestmentNVIDIA BioNeMo Platform Gains Eli Lilly, Thermo Fisher as Pharma Firms Accelerate AI Infrastructure SpendSalvado•Apr 9, 2026
Corporate StrategyMultinational Tech Giants Face Dual AI Infrastructure Costs as US-China Hardware Split DeepensSalvado•Mar 30, 2026
Corporate StrategyHuawei 950PR Chip Gains Traction as ByteDance and Alibaba Plan Orders Amid US Export RestrictionsSalvado•Mar 30, 2026
Corporate StrategyUS-China chip restrictions drive dual AI infrastructure markets as Huawei accelerates domestic alternativeSalvado•Mar 30, 2026
Corporate InnovationNVIDIA Signs Eli Lilly, Thermo Fisher to BioNeMo Platform in Pharmaceutical AI PushSalvado•Mar 29, 2026
Corporate StrategyNVIDIA Secures Lilly and Thermo Fisher as BioNeMo Platform Anchors AI-Driven Drug Discovery EcosystemSalvado•Mar 26, 2026
AI Infrastructure InvestmentOpenAI Chief Scientist Predicts 'Research Lab in Data Center' as AI Infrastructure Market SplitsSalvado•Mar 26, 2026
Corporate StrategyNVIDIA Expands Biotech AI Infrastructure Through Partnerships with Thermo Fisher and Eli LillySalvado•Mar 25, 2026
Corporate AI InvestmentOpenAI Pushes Fully Automated AI Researchers as Enterprise Infrastructure Spend AcceleratesSalvado•Mar 24, 2026
Corporate StrategyNVIDIA BioNeMo Platform Secures Eli Lilly and Thermo Fisher as Strategic Partners in Drug Discovery PushSalvado•Mar 23, 2026
Corporate PartnershipsNVIDIA BioNeMo Wins Thermo Fisher, Eli Lilly as AI Drug Discovery PartnersSalvado•Mar 22, 2026
